statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PAVmed Provides Business Update and First Quarter 2024 Financial Results PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13, 2024 Lucid strengthens...

PAVmed Provides Business Update and First Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13...

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall PR Newswire NEW...

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors Lucid Diagnostics Closes Series B / B-1 Preferred Stock...

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 PR Newswire NEW YORK...

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer...

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer Testing

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN...

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual...

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Lucid Diagnostics (NASDAQ:LUCD - Get Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF - Get Free Report) are both medical companies, but which is the superior business? We will compare the two...

Lucid Diagnostics (NASDAQ:LUCD) vs. CellaVision AB (publ) (OTCMKTS:CLVSF) Financial Comparison

Anthony Vendetti, an analyst from Maxim Group, has initiated a new Buy rating on PAVmed (PAVM). Anthony Vendetti has given his Buy rating due to a...

Buy Rating Affirmed for PAVmed with Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Watchers	1,354
52-Wk Low	$0.6301
52-Wk High	$1.85

Volume	2,332.00
52-Wk High	$1.85
52-Wk Low	$0.6301

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.20	--	--	N/A
Q1'24	-$0.24	-$0.99	-312.50%	MISSED
Q4'23	-$0.23	-$1.33	-473.28%	MISSED
Q3'23	-$0.24	-$0.22	7.37%	BEAT
Q2'23	-$0.28	-$0.23	18.58%	BEAT

LUCD Lucid Diagnostics Inc

About

Feed

News

Earnings

Fundamentals